Amarin Corp Plcuk (AMRN) Gross Margin Growth (5y) (2018 - 2026)

Amarin Corp Plcuk (AMRN) Gross Margin Growth (5y) (2018 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Amarin Corp Plcuk 6.77 Bn 6.59 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4,070.00
Dec 31, 2025 -3,214.00
Sep 30, 2025 -3,416.00
Jun 30, 2025 -948.00
Mar 31, 2025 -1,773.00
Dec 31, 2024 -9,395.00
Sep 30, 2024 -3,889.00
Jun 30, 2024 -1,404.00
Mar 31, 2024 -2,016.00
Dec 31, 2023 -1,696.00
Sep 30, 2023 -3,038.00
Jun 30, 2023 -2,237.00
Mar 31, 2023 -2,001.00
Dec 31, 2022 -458.00
Sep 30, 2022 -489.00
Jun 30, 2022 -2,860.00
Mar 31, 2022 17.00
Dec 31, 2021 658.00
Sep 30, 2021 388.00
Jun 30, 2021 595.00